Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1627 1629
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18560520 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | Non-Final OA | BRISTOL-MYERS SQUIBB COMPANY |
| 18605474 | COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE | Non-Final OA | Ramot at Tel-Aviv University Ltd. |
| 18001889 | A NUTRITIONAL COMPOSITION COMPRISING 3-HYDROXYBUTYRIC ACID TO IMPROVE THE GASTROINTESTINAL BARRIER | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18560558 | QUINAZOLINE DERIVATIVES TARGETING R(CCUG) REPEATS IN MYOTONIC DYSTROPHY TYPE 2 | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 17773257 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTION | Non-Final OA | UNIVERSITY OF SOUTH FLORIDA |
| 18599953 | EFFICIENT STABILIZER IN CONTROLLING SELF ACCELERATED DECOMPOSITION TEMPERATURE OF PEROXYCARBOXYLIC ACID COMPOSITIONS WITH MINERAL ACIDS | Non-Final OA | ECOLAB USA INC. |
| 16551594 | COMPOSITIONS AND METHODS FOR DELIVERING TETRAHYDROCANNABINOL AND KETONE BODIES | Non-Final OA | AXCESS GLOBAL SCIENCES, LLC |
| 18028338 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS AND ALLEVIATING FATIGUE | Final Rejection | University of Miami |
| 18737768 | ANTIMICROBIAL COMPOSITIONS | Non-Final OA | Curie Co. Inc. |
| 17438155 | TRISUBSTITUTED PYRAZOLO [1,5-A] PYRIMIDINE COMPOUNDS AS CDK7 INHIBITORS | Non-Final OA | THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE |
| 18568031 | USE OF MMP INHIBITORS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME | Non-Final OA | Foresee Pharmaceuticals USA, Inc. |
| 18568043 | SAFE USE OF MMP-12 INHIBITOR | Non-Final OA | Yuhua LI |
| 18275521 | AGENT FOR PREVENTING OR IMPROVING PERIPHERAL NEUROPATHY | Non-Final OA | KOBAYASHI PHARMACEUTICAL CO., LTD. |
| 18555776 | METHOD FOR OBTAINING RIFAPENTINE WITH A NEW CRYSTALLINE FORM | Non-Final OA | INTERQUIM S.A. DE C.V. |
| 18555106 | SIRTUIN OR KLOTHO ACTIVATOR OR EXPRESSION ENHANCER, NAD+ INCREASING AGENT, AND SENOLYTIC AGENT | Non-Final OA | WAKUNAGA PHARMACEUTICAL CO., LTD. |
| 18280628 | COMPOSITION FOR AMELIORATING INFLAMMATION OF PERIODONTAL TISSUE | Non-Final OA | Institute of Rheological Function of Food Co., Ltd. |
| 18279379 | 7-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor | Non-Final OA | Provincial Health Services Authority |
| 18360200 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION | Final Rejection | Cereno Scientific AB |
| 18225093 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | Non-Final OA | Keto Innovations, LLC |
| 18319334 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION | Non-Final OA | Keto Innovations, LLC |
| 18254979 | SENOTHERAPEUTIC SUBSTANCE | Non-Final OA | BIONEXA S.R.L |
| 18059142 | SYSTEMS AND METHODS FOR SUPPLYING NUTRITIONAL SUPPLEMENTS THAT ELIMINATE PERVASIVE ODORS | Non-Final OA | Zinpro Corporation |
| 17772139 | COMPOSITION FOR PREVENTING AND/OR TREATING NEURODEGENERATIVE DISORDERS | Non-Final OA | Hideaki HARA |
| 17690680 | Methods and Compositions to Inhibit Symptoms Associated with Opioid Withdrawal | Final Rejection | SEN-JAM PHARMACEUTICAL LLC |
| 15348149 | COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) AS AN ANIMAL FEED ADDITIVE | Final Rejection | Metabolic Technologies, Inc. |
| 16881375 | DOSING METHODS FOR TREATING INFLAMMATORY BOWEL CONDITIONS | Final Rejection | Intact Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy